The platform functions by integrating primary research, prescription claims, and CRM data through Trinity Weave, a proprietary unified data fabric. This approach allows life sciences organizations to test scenarios and simulate conversations with high-fidelity models grounded in real-world evidence. According to CEO Scott Evangelista, the technology is designed to amplify human expertise rather than replace it, combining decades of industry knowledge with advanced computing to accelerate decision-making.

Jonathan Jenkins, who leads AI and digital solutions at the firm, noted that the system moves commercial teams away from traditional, static reporting. By providing dynamic intelligence that evolves with every interaction, the platform aims to reduce costs while increasing the certainty of commercial outcomes. The award highlights Trinity’s broader push to standardize the responsible application of artificial intelligence in pharmaceutical and biotech market strategies.